BioFire FilmArray BCID2 Versus VITEK-2 System in Determining Microbial Etiology and Antibiotic-Resistant Genes of Pathogens Recovered from Central Line-Associated Bloodstream Infections
Overview
Authors
Affiliations
Central line-associated bloodstream infection (CLABSI) is among the most serious hospital acquired infections. Therefore, the rapid detection of the causative microorganism is of crucial importance to allow for the appropriate antimicrobial therapy. In the present study, we analyzed the clinical performance of the BioFire FilmArray Blood Culture Identification 2 (BCID2) panel in the identification of 33 microbial species and 10 antibiotic resistance genes in comparison to the VITEK-2 system. A total of 104 blood specimens were included. The FilmArray BCID2 results were concordant with the VITEK-2 system in 69/97 specimens (71.1%). Non-concordance was either due to the detection of more pathogens by the FilmArray BCID2 23/28 (82%) or microbial species were misidentified 5/28 (18%). Hence, in comparison to the VITEK-2 system, the FilmArray BCID2 panel showed an overall sensitivity of 75.8% (95% CI, 66-83%) and an overall specificity of 98% (95% CI, 97-98.8%) in detecting microbial species. For the resistance genes, the FilmArray BCID was able to detect the presence of CTX-M gene in 23 Gram-negative isolates, NDM and OXA-48- like genes in 14 and 13 isolates, respectively. The A and C genes were found in 23 species, while A, C and MREJ genes were found in 4 isolates. The sensitivity and specificity for detecting resistance genes by the FilmArray BCID2 was 90% (95% CI, 81.4-95%) and 99.6% (95% CI, 99-100%), respectively. As concluded, the present study emphasizes the high sensitivity and specificity of the FilmArray BCID2 in the rapid and reliable detection of different bacteria and fungi from positive blood culture bottles, as well as the accurate detection of various antibiotic resistance markers.
Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis.
Liborio M, Harris P, Ravi C, Irwin A Microorganisms. 2024; 12(9).
PMID: 39338498 PMC: 11434042. DOI: 10.3390/microorganisms12091824.
Hu Y, Bi S, Zhang Z, Kong N Curr Microbiol. 2024; 81(9):289.
PMID: 39078504 DOI: 10.1007/s00284-024-03818-2.
Kamel N, Abdalla M, Al Ali A, Alshahrani M, Aboshanab K, El Borhamy M Infect Drug Resist. 2024; 17:2249-2260.
PMID: 38854781 PMC: 11162205. DOI: 10.2147/IDR.S463868.
Devrim I, Ayhan F, Kacar P, Ozenen G, Bayram A, Ergun D Eur J Pediatr. 2023; 183(3):1353-1360.
PMID: 38150026 DOI: 10.1007/s00431-023-05381-7.
Mauri C, Consonni A, Briozzo E, Giubbi C, Meroni E, Tonolo S Antibiotics (Basel). 2023; 12(8).
PMID: 37627667 PMC: 10451250. DOI: 10.3390/antibiotics12081247.